全文获取类型
收费全文 | 1262篇 |
免费 | 84篇 |
国内免费 | 135篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 13篇 |
妇产科学 | 86篇 |
基础医学 | 140篇 |
口腔科学 | 6篇 |
临床医学 | 271篇 |
内科学 | 230篇 |
皮肤病学 | 12篇 |
神经病学 | 108篇 |
特种医学 | 30篇 |
外科学 | 169篇 |
综合类 | 66篇 |
一般理论 | 1篇 |
预防医学 | 55篇 |
眼科学 | 8篇 |
药学 | 150篇 |
中国医学 | 24篇 |
肿瘤学 | 108篇 |
出版年
2024年 | 1篇 |
2023年 | 8篇 |
2022年 | 16篇 |
2021年 | 23篇 |
2020年 | 18篇 |
2019年 | 24篇 |
2018年 | 53篇 |
2017年 | 31篇 |
2016年 | 23篇 |
2015年 | 41篇 |
2014年 | 50篇 |
2013年 | 76篇 |
2012年 | 105篇 |
2011年 | 88篇 |
2010年 | 49篇 |
2009年 | 62篇 |
2008年 | 84篇 |
2007年 | 146篇 |
2006年 | 76篇 |
2005年 | 94篇 |
2004年 | 39篇 |
2003年 | 37篇 |
2002年 | 32篇 |
2001年 | 41篇 |
2000年 | 44篇 |
1999年 | 24篇 |
1998年 | 19篇 |
1997年 | 21篇 |
1996年 | 17篇 |
1995年 | 10篇 |
1994年 | 4篇 |
1993年 | 13篇 |
1992年 | 29篇 |
1991年 | 11篇 |
1990年 | 13篇 |
1989年 | 12篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1986年 | 4篇 |
1985年 | 4篇 |
1984年 | 3篇 |
1983年 | 8篇 |
1982年 | 1篇 |
1981年 | 1篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有1481条查询结果,搜索用时 15 毫秒
31.
32.
Ching-Wei D. Tzeng Matthew H. G. Katz Jason B. Fleming Jeffrey E. Lee Peter W. T. Pisters Holly M. Holmes Gauri R. Varadhachary Robert A. Wolff James L. Abbruzzese Jean-Nicolas Vauthey Thomas A. Aloia 《Journal of gastrointestinal surgery》2014,18(1):146-156
Background
We previously described the clinical classification of patients with resectable pancreatic tumor anatomy but marginal performance status (PS) or reversible comorbidities as “borderline resectable type C” (BR-C). This study was designed to analyze the incidence and risk factors for post-pancreaticoduodenectomy (PD) morbidity/mortality in a multi-institutional cohort of BR-C patients.Methods
Elective PDs were evaluated from the 2005-10 ACS-NSQIP database. BR-C was defined as age?≥?80, poor PS, weight loss?>?10 %, pulmonary disease, recent myocardial infarction/angina, stroke history, and/or preoperative sepsis. Variables associated with 30-day postoperative major complications (PMC) and mortality were analyzed.Results
A total of 3,033/8,266 (36.7 %) patients were BR-C. BR-C patients were more likely to suffer PMC (31.3 vs. 26.2 %) and mortality (4.1 vs. 2.3 %). BR-C patients with PMC suffered 50 % higher mortality versus non-BR-C patients with PMC (11.5 vs. 7.7 %) (all p?<?0.001). For BR-C patients, multivariate analysis identified the following risk factors for PMC or mortality: albumin?<?3.5 g/dL, dyspnea, preoperative sepsis, age?≥?80, poor PS, anesthesia score?≥?4, and intraoperative transfusion?≥?4 units.Conclusions
Nationwide, one third of patients undergoing PD are medically borderline. These BR-C patients are at higher risk for and less able to be rescued from PMC. Surgeons should identify and optimize comorbidities and utilize prehabilitation to address functional deficits before elective PD. 相似文献33.
Characterization and quantitation of the circulating forms of serum transferrin receptor using domain-specific antibodies 总被引:1,自引:0,他引:1
To characterize the nature of the immunoreactive transferrin receptor in human serum, antisera were developed to peptide sequences of the extracellular domain of human transferrin receptor between amino acids 107 and 120 and the intracellular domain between amino acids 40 and 54. Antisera against the extracellular domain exhibited reactivity against both purified intact receptor and immunopurified circulating receptor, whereas antisera against the intracellular domain reacted only with intact receptor. Using competitive binding enzyme-linked immunosorbent assays, transferrin receptor in ultracentrifuged sera from normal subjects and patients with sickle cell anemia could be detected with antisera against the extracellular but not the intracellular domain. When the pellet obtained by ultracentrifugation of these sera was assayed after solubilization in 1% teric (polyoxyethylene-9-lauryl ether), only 0.6% of total serum receptor was detected in normal subjects and 3.8% in subjects with sickle cell disease. Roughly equal amounts of this pelleted immunoactivity were detected with antibodies against the extracellular and intracellular domains. These results indicate that less than 1% of transferrin receptor in normal human sera is intact receptor consistent with an exosomal origin and that virtually all circulating transferrin receptor is in the form of a truncated extracellular domain. 相似文献
34.
35.
Chuan-Wen Ho Tzong-Der Tzeng Tzen-Yuh Chiang Chih-Yao Li Feng-Jiau Lin 《Conservation Genetics Resources》2014,6(3):547-549
Nine polymorphic microsatellite makers were isolated and characterized in 20 individuals of Parapenaeopsis hardwickii collected from the fishing ground near Ilan, Taiwan. Number of alleles per locus ranged from 3 to 8, observed and expected heterozygosities ranged from 0.5263 to 0.7632, and from 0.4225 to 0.8044, respectively. Only one locus showed a Hardy–Weinberg equilibrium deviation. No linkage disequilibrium was found among these studied loci. This set of microsatellites provides a suitable tool for population genetic structure and fishery management of this species in Asian coastal waters. 相似文献
36.
37.
38.
利福平外用致原位肝移植术后患者过敏反应1例 总被引:1,自引:0,他引:1
肝炎后肝硬化患者,原发性肝癌行原位肝移植术,于术后7 d皮肤破溃处涂利福平胶囊粉后出现过敏反应.利福平为临床常用的广谱抗菌素,外用后快速导致过敏反应未见报道, 该病例既往无过敏史,特殊之处在于为原位肝移植术后患者,移植术后用药有很多特殊之处,可供参考的资料不多.抗过敏治疗上以尽快纠正低氧血症对移植肝功能的恢复至关重要. 相似文献
39.
40.
Jui-Lin Fan Ricardo C Nogueira Patrice Brassard Caroline A Rickards Matthew Page Nathalie Nasr Yu-Chieh Tzeng 《Journal of cerebral blood flow and metabolism》2022,42(3):454
Restoring perfusion to ischemic tissue is the primary goal of acute ischemic stroke care, yet only a small portion of patients receive reperfusion treatment. Since blood pressure (BP) is an important determinant of cerebral perfusion, effective BP management could facilitate reperfusion. But how BP should be managed in very early phase of ischemic stroke remains a contentious issue, due to the lack of clear evidence. Given the complex relationship between BP and cerebral blood flow (CBF)—termed cerebral autoregulation (CA)—bedside monitoring of cerebral perfusion and oxygenation could help guide BP management, thereby improve stroke patient outcome. The aim of INFOMATAS is to ‘identify novel therapeutic targets for treatment and management in acute ischemic stroke’. In this review, we identify novel physiological parameters which could be used to guide BP management in acute stroke, and explore methodologies for monitoring them at the bedside. We outline the challenges in translating these potential prognostic markers into clinical use. 相似文献